246 related articles for article (PubMed ID: 25436361)
1. The effect of hepatocellular carcinoma bile duct tumor thrombi in liver transplantation.
Kim JM; Kwon CH; Joh JW; Park JB; Gwak MS; Lee JH; Kim GS; Kim SJ; Lee SK
Hepatogastroenterology; 2014 Sep; 61(134):1673-6. PubMed ID: 25436361
[TBL] [Abstract][Full Text] [Related]
2. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
3. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
[TBL] [Abstract][Full Text] [Related]
4. Risk factors of microvascular invasion, portal vein tumor thrombosis and poor post-resectional survival in HBV-related hepatocellular carcinoma.
Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
Hepatogastroenterology; 2014 Sep; 61(134):1696-703. PubMed ID: 25436365
[TBL] [Abstract][Full Text] [Related]
5. Living donor liver transplantation for hepatocellular carcinoma.
Isik B; Ince V; Karabulut K; Kayaalp C; Yilmaz S
Transplant Proc; 2012; 44(6):1713-6. PubMed ID: 22841251
[TBL] [Abstract][Full Text] [Related]
6. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
7. Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation.
Lee S; Hyuck David Kwon C; Man Kim J; Joh JW; Woon Paik S; Kim BW; Wang HJ; Lee KW; Suh KS; Lee SK
Liver Transpl; 2014 Sep; 20(9):1057-63. PubMed ID: 24862741
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of resection for hepatocellular carcinoma with macroscopic bile duct tumor thrombus.
Oba A; Takahashi S; Kato Y; Gotohda N; Kinoshita T; Shibasaki H; Ikeda M; Konishi M
Anticancer Res; 2014 Aug; 34(8):4367-72. PubMed ID: 25075073
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characteristics and liver stem cell marker expression in hepatocellular carcinoma involving bile duct tumor thrombi.
Pang YB; Zhong JH; Luo XL; Ou C; Guo Z; Xiang BD; Peng NF; Li LQ
Tumour Biol; 2016 May; 37(5):5879-84. PubMed ID: 26586401
[TBL] [Abstract][Full Text] [Related]
10. Alpha-fetoprotein and
Yang Z; Luo FZ; Wang S; Lerut J; Zhuang L; Li QY; Xu X; Zheng SS
Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):229-234. PubMed ID: 32303439
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting recurrence and survival after living donor liver transplantation for hepatocellular carcinoma.
Abdel-Wahab M; Sultan AM; Fathy OM; Salah T; Elshobary MM; Elghawalby NA; Yassen AM; Elsarraf WM; Elsaadany MF; Zalatah K
Hepatogastroenterology; 2013; 60(128):1847-53. PubMed ID: 24719918
[TBL] [Abstract][Full Text] [Related]
12. Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma.
Na GH; Kim EY; Hong TH; You YK; Kim DG
HPB (Oxford); 2016 Jan; 18(1):98-106. PubMed ID: 26776857
[TBL] [Abstract][Full Text] [Related]
13. The clinical outcomes of patients with portal vein tumor thrombi after living donor liver transplantation.
Choi HJ; Kim DG; Na GH; Hong TH; Bae SH; You YK; Choi JY; Yoon SK
Liver Transpl; 2017 Aug; 23(8):1023-1031. PubMed ID: 28480517
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
[TBL] [Abstract][Full Text] [Related]
16. Predictive Value of Alpha-fetoprotein in the Survival of Living Donor Liver Transplantation Recipients for Hepatocellular Carcinoma.
Jiang L; Liao A; Yan L; Li B; Zhu W; Wen T
Hepatogastroenterology; 2014 May; 61(131):747-51. PubMed ID: 26176068
[TBL] [Abstract][Full Text] [Related]
17. Tumor Characteristics and Long-Term Outcome of Incidental Hepatocellular Carcinoma After Orthotopic Liver Transplant.
Mourad MM; Algarni A; Aly MA; Gunson BK; Mergental H; Isaac J; Muiesan P; Mirza D; Perera MT; Bramhall SR
Exp Clin Transplant; 2015 Aug; 13(4):333-8. PubMed ID: 26295183
[TBL] [Abstract][Full Text] [Related]
18. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
Lee KW; Yi NJ; Suh KS
Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
[TBL] [Abstract][Full Text] [Related]
19. AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.
Yaprak O; Akyildiz M; Dayangac M; Demirbas BT; Guler N; Dogusoy GB; Yuzer Y; Tokat Y
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):256-61. PubMed ID: 22672818
[TBL] [Abstract][Full Text] [Related]
20. Incidental microscopic bile duct tumor thrombi in hepatocellular carcinoma after curative hepatectomy: a matched study.
Kim JM; Kwon CHD; Joh JW; Sinn DH; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
Medicine (Baltimore); 2015 Feb; 94(6):e450. PubMed ID: 25674733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
